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doi:10.1016/j.ejvs.2009.07.006Abstract Background: Chronic atrial fibrillation (AF) in a non-surgical setting is associated
with cardiovascular events. However, the prognosis of transient new-onset AF during vascular
surgery is unknown.
Objective: The purpose of this study is to investigate the prognosis of new-onset AF during
vascular surgery using continuous electrocardiographic monitoring (continuous-ECG).
Methods: In this study, 317 patients, all in sinus rhythm, scheduled for major vascular surgery
were screened for cardiac risk factors. Continuous-ECG recordings for 72 h and standard ECG
on days 3, 7 and 30 were used to identify new-onset AF. Cardiac troponin T (cTnT) was
measured routinely after surgery. Study endpoint was a composite of cardiac death, myocar-
dial infarction, unstable angina and stroke (cardiovascular events) at 30 days after surgery and
during late follow-up. Median follow-up was 12 (interquartile range 2e28) months.
Results: New-onset AF was noted in 15 (4.7%) patients. All but three patients returned spon-
taneously to sinus rhythm. The composite endpoint of cardiovascular events within 30 days
and during late follow-up occurred in 34 (11%) and 62 (20%) patients, respectively. Multivariate
regression analysis showed that new-onset AF was associated with perioperative (hazard ratio
(HR) 6.0; 95% CI: 2.4e15) and late cardiovascular events (HR 4.2, 95% CI: 2.1e8.8).
Conclusion: New-onset AF during vascular surgery is associated with an increased incidence of
30-day and late cardiovascular events.
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ty for Vascular Surgery. PublisheCardiovascular complications are a major cause for
morbidity and mortality in patients undergoing non-cardiac
vascular surgery.1 It is estimated that after non-cardiac
surgery, 2e10% of patients develop cardiac arrhythmias, of
which atrial fibrillation (AF) is the most common form.2e5
AF is facilitated by electrolyte disturbances, hypoxia and
acidosis. Postoperative AF is associated with a prolongedd by Elsevier Ltd. All rights reserved.
684 T.A. Winkel et al.hospital stay, as well as neurological and cardiac compli-
cations and increased health-care costs. It was estimated
that after cardiac surgery atrial tachyarrhythmias increased
costs by $6356 per patient.6 Patients with recurrent
episodes of preoperative AF are probably at the greatest
risk for this adverse outcome.
The impact of new-onset AF in the perioperative period
after vascular surgery is ill defined. Importantly, the inci-
dence of postoperative AF is closely related to the exten-
siveness of cardiac rhythm monitoring. Till date, detection
of cardiac arrhythmias was most frequently performed with
intermittent and/or daily electrocardiographic (ECG)
monitoring and based on patients’ complaints. However,
this might be insufficient to detect the true incidence of
new-onset AF and its impact on perioperative and long-
term outcome after vascular surgery. It must be considered
that perioperative new-onset AF is often short lived and
asymptomatic, making detection difficult.
Therefore, the purpose of this study was to assess the
incidence and impact of perioperative new-onset AF in
vascular surgery patients using continuous-ECG registration
for the first 48 h after surgery.
Methods
Study population
The study population consisted of 409 patients undergoing
electiveabdominal aortic aneurysmrepair orperipheral artery
bypass surgery at the Erasmus Medical Center in Rotterdam,
the Netherlands, during the period 2004e2009. Patients with
a history of cardiac arrhythmias (nZ 28), cardiac pacemaker
(nZ 6), left ventricular hypertrophy (nZ 33) and left or right
bundle branch block (nZ 25) were excluded. The hospital’s
ethical committee approved the study.
Preoperative cardiovascular screening
We determined the cardiac risk score for each patient in
our data set, and a point was assigned to each of the
following characteristics: advanced age (> 70 years),
history of myocardial infarction (MI), angina pectoris,
congestive heart failure, stroke, diabetes mellitus (fasting
glucose level  7.0 mmol l1 or use of insulin or oral
glucose-lowering medication) and renal insufficiency
(serum creatinine > 170 mmol l1). Based on the number of
these risk factors, patients were stratified into low- (no risk
factors), intermediate- (one or two risk factors) and high-
risk (at least three risk factors) categories.7 Furthermore,
all patients were screened for hypertension (blood pressure
 140/90 mmHg or blood-pressure-lowering medication),
hypercholesterolaemia (plasma cholesterol level
 5.5 mmol l1 or use of cholesterol-lowering medication),
smoking status and chronic obstructive pulmonary disease
(defined as a forced expiratory volume in 1 s (FEV1) < 70%
of age- and gender-predictive value or medication use).8
Detection of atrial fibrillation
Patients were continuously monitored with a 10-electrode,
12-lead digital ECG recorder (DR180þ Digital Recorder,NorthEast Monitoring Inc., Maynard, MA, USA), starting 1
day before surgery and continuing up to 2 days after.
Continuous-ECG recordings were started 1 day prior to
surgery, depending on the time of admission of the patient
to the vascular surgery ward. Recordings were performed in
the continuous 12-lead mode with a recording length of 10 s
every minute. The frequency response was 0.05e150 Hz
Electrocardiographic data were initially processed by
a technician and analysed by two experienced cardiologists
who were blinded to the patient’s clinical data. After
excluding all artefacts, the ambulatory electrocardiog-
raphy recordings were analysed for new-onset AF. On the
ECG, AF is characterised by the replacement of consistent P
waveswith rapid oscillations or fibrillatorywaves that vary in
amplitude, shape and timing, associated with an irregular,
frequently rapid, ventricular response when atrioventricular
conduction is intact.9 Continuous-ECG recordings were
analysed off-line. Postoperatively standard ECGs weremade
routinely on day 3, 7 and 30, and/or at discharge and
whenever clinically indicated by chest pain or complaints
of dyspnoea.
Perioperative outcome
The perioperative endpoint was a composite of cardiac
death, MI, unstable angina pectoris and stroke (cardiovas-
cular events) within 30 days after surgery. After surgery,
cardiac troponin T (cTnT) levels were routinely measured
on postoperative days 1, 3, 7, 30 and/or at discharge and
whenever clinically indicated by chest pain or ECG changes
consistent with myocardial ischaemia or infarction. MI was
defined as the presence of two out of the following three
criteria: (1) characteristic ischaemic symptoms lasting
> 20 min, (2) electrocardiographic changes including acute
ST elevation, followed by appearance of Q waves or loss of
R waves, or new left bundle branch block, or new persistent
T-wave inversion for at least 24 h, or new ST segment
depression which persists > 24 h and (3) a positive troponin
T, that is, > 0.10 ngml1 with characteristic rise and fall.10
Cardiovascular death was defined as any death with
a cardiovascular cause, including those following a cardiac
procedure, cardiac arrest, MI, pulmonary embolus, stroke
or sudden deaths not ascribed to other causes.11
Long-term outcome
During follow-up, outpatient visits were scheduled every 3
months after discharge. Long-term study endpoints were
cardiovascular events, that is, cardiac death, MI, unstable
angina pectoris and stroke. Cardiac death was defined as
death caused by acute MI, cardiac arrhythmias, congestive
heart failure or sudden death. Survival status was ascer-
tained by contacting the civil service registry.
Data analysis
Continuous data are expressed as means standard devia-
tion (SD) and are compared using the Student’s t test.
Categorical variables are described as numbers and
percentages, and analysed using the chi-square test or
Fisher’s exact test, as appropriate. The association of new-
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by multivariate Cox regression analysis. All co-variables
associated with perioperative cardiovascular complications
(P-value <0.20 in univariate analysis) were included in the
multivariate model. The number of outcome events in the
study was limited. Therefore, to avoid over fitting, and to
enable assessment of the relation between clinical risk
factors and the composite endpoint, we used the risk score
described by Boersma et al.7 In multivariate analysis,
adjustments were made for risk factors, cardiac risk score,
site of surgery and open or endovascular procedure. Hazard
ratios (HRs) are given with 95% confidence intervals (CIs).
For all tests, a p-value of less than 0.05 (two-sided) was
considered significant. All analyses were performed using
SPSS 15.0 statistical software (SPSS Inc., Chicago, IL, USA).
Results
Patient characteristics
A total of 317 patients undergoing abdominal aortic
aneurysm repair (nZ 216) or peripheral arterial bypass
surgery (nZ 101) were analysed. Their mean age was
68.6 9.5 years and 79% were male. According to the
cardiac risk score, 23% of patients had low cardiac risk,
54% intermediate cardiac risk and 23% high cardiac risk.
The baseline clinical characteristics are listed in Table 1.
Patients who developed new-onset AF were significantlyTable 1 Baseline characteristics.
All (nZ 317)
Age, years SD 68.6 9.5
Males e no. (%) 250 (79)
Cardiovascular risk factors e no. (%)
History of myocardial infarction 100 (32)
History of angina pectoris 60 (19)
History of congestive heart failure 24 (8)
Diabetes mellitus 63 (20)
Renal dysfunction 31 (10)
History of TIA or CVA 48 (15)
Hypertension 153 (48)
COPD 133 (42)
Medication e no. (%)
Beta-blockers 305 (96)
Statins 261 (82)
Antiplatelet therapy 217 (68)
Oral anticoagulants 48 (15)
ACE-inhibitors 86 (27)
Calcium channel blocking agents 82 (26)
Site of surgery e no. (%)
Abdominal aorta 216 (68)
Endovascular 95
Open 121
Lower extremity artery 101 (32)
AFZ atrial fibrillation; TIAZ transient ischaemic attack; CVAZ ce
disease; ACEZ angiotensin converting enzyme.older (pZ 0.02). Except for age, there were no significant
differences in baseline characteristics between the two
groups.
New-onset AF
Continuous-ECG monitoring was started 12.1 7.2 h prior
to surgery. During 20 775 patient-hours of continuous 12-
lead ECG monitoring (65.5 20.2 h per patient), 13 (4%)
patients developed new-onset AF. In all but one continuous-
ECG recording, new-onset AF occurred postoperatively. In
addition, in two patients, new-onset AF was noted on
standard ECGs between day 3 and 7 after surgery. A vast
majority of patients (80%) were without clinical symptoms.
In three patients, exacerbating heart failure symptoms
were present and were treated by additional diuretics and
digoxin therapy. All patients were on perioperative beta-
blocker therapy as well as low-molecular-weight heparins.
All but three patients with new-onset AF returned to sinus
rhythm at 30 days postoperatively, as confirmed by stan-
dard ECG.
There were no significant differences in the type of
anaesthesia or the duration of anaesthesia between the
two groups. In the group of patients with new-onset AF, 80%
had general anaesthesia, as compared to 61% in those
without new-onset AF (pZ 0.80). The mean duration of
anaesthesia did not differ between the two groups (4.5 vs.
4.3 h, pZ 0.63).No AF (nZ 302) New-onset AF (nZ 15)
68.3 9.5 74.4 8.9
237 (79) 13 (85)
97 (32) 3 (20)
59 (20) 1 (7)
22 (7) 2 (13)
61 (20) 2 (13)
28 (9) 3 (20)
44 (15) 4 (27)
144 (48) 9 (60)
129 (43) 4 (27)
291 (96) 14 (93)
249 (83) 12 (80)
207 (69) 10 (67)
44 (15) 4 (27)
81 (27) 5 (33)
76 (25) 6 (40)
205 (68) 11 (63)
91 4
114 7
97 (32) 4 (27)
rebrovascular accident; COPDZ chronic obstructive pulmonary
Table 2 Multivariate Cox regression analysis for perioperative cerebro-cardiovascular outcome.
Univariate Multivariate
HR 95% CI p-value HR 95% CI p-value
New-onset atrial fibrillation 4.9 2.0e12 <0.001 6.0 2.4e15 <0.001
Clinical cardiac risk
Low 1
Intermediate 2.4 0.7e8.3 0.16 3.0 0.9e10 0.08
High 5.7 1.7e20 0.006 7.7 2.2e27 0.002
Other risk factors
Male 0.8 0.4e2.0 0.78
Hypertension 2.1 1.0e4.2 0.04 2.0 1.0e4.0 0.06
COPD 1.4 0.7e2.8 0.31
Surgery
Aortic 1 0.01 1
Peripheral 0.3 0.1e0.8 0.2 0.1e0.5 0.001
Type of surgery
Open 1 0.11 1
Endovascular 0.5 0.2e1.2 0.2 0.1e0.6 0.001
Figure 1 Long-term outcome after vascular surgery of
patients with new-onset perioperative atrial fibrillation
(nZ 15) and patients without new-onset atrial fibrillation
(nZ 302). Multivariate regression analysis showed that
patients with new-onset AF had a four-fold increased risk for
late cardiovascular events. (HR 4.2, 95% CI 2.1e8.8).
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In total, 63 (19.9%) patients experienced cTnT release
within 30 days after surgery. A total of 70 patients devel-
oped myocardial ischaemia during continuous-ECG moni-
toring. Eight patients with perioperative new-onset AF also
had signs of myocardial ischaemia. The incidence of
myocardial ischaemia in patients with new-onset AF was
significantly higher compared with those without new-onset
AF (53% vs. 21%, pZ 0.01). New-onset AF was preceded by
myocardial ischaemia in half of the cases.
Seven patients with new-onset AF had a combination of
cTnT release and myocardial ischaemia detection.
A non-fatal MI and cardiac death was noted in 21 (6.6%)
and 12 (3.8%) patients, respectively. One patient experi-
enced a non-fatal perioperative stroke. The incidence of
the composite perioperative outcome was noted in 34
(10.7%) patients. In univariate analysis, new-onset AF was
associated with an increased risk of perioperative cardio-
vascular events (HR 4.9, 95% confidence interval (CI):
2.0e11.9, p< 0.001, Table 2). After correcting for risk
factors, type and site of surgery, multivariate regression
analysis showed that new-onset AF was still associated
with perioperative cardiovascular events (HR 6.0, 95% CI
2.4e15.0, p< 0.001, Table 2).
Within a median follow-up of 12 months (interquartile
range 2e28 months) after surgery, 35 (11.0%) patients expe-
rienced a non-fatal MI, nine (2.8%) unstable angina pectoris
and four (1.3%) stroke, whereas 34 (10.7%) died due to
a cardiac cause. In total, a combined endpoint of long-term
cardiovascular events occurred in 62 (19.6%) patients. In
univariate analysis, perioperative new-onset AF was associ-
atedwithan increased riskof long-termcardiovascularevents
(HR 4.4, 95% CI: 2.1e8.8, p< 0.001, Fig. 1). This association
between perioperative AF and long-term prognosis persisted
when other cardiovascular risk factors, type and site of
surgery were added to themultivariate Cox regression model
(HR 4.2, 95% CI: 2.1e8.8, p< 0.001, Table 3).Discussion
The current study shows that transient and predominantly
asymptomatic new-onset AF during vascular surgery is
associated with an increased risk for perioperative and
long-term cardiovascular events. Patients with new-onset
AF had an almost fivefold increased risk for perioperative
cardiovascular complications. This risk persisted in the first
year after surgery as patients with new-onset AF experi-
enced a fourfold increased risk for late complications.
AF is a supraventricular tachyarrhythmia characterised
by uncoordinated atrial activation with consequent dete-
rioration of mechanical function. Factors affecting hae-
modynamic function during AF are loss of synchronous atrial
Table 3 Multivariate Cox regression analysis for long-term cerebro-cardiovascular outcome.
Univariate Multivariate
HR 95% CI p-value HR 95% CI p-value
New-onset atrial fibrillation 4.4 2.1e8.8 <0.001 4.2 2.1e8.8 <0.001
Clinical cardiac risk
Low 1
Intermediate 3.7 1.3e10 0.02 4.0 1.4e11 0.01
High 9.2 3.2e26 <0.001 10.7 3.7e31 <0.001
Other risk factors
Male 1.3 0.7e2.5 0.43
Hypertension 1.9 1.2e3.3 0.01 1.7 1.0e2.9 0.04
COPD 1.4 0.8e2.3 0.20
Surgery
Aortic 1 0.26 1
Peripheral 0.7 0.4e1.3 0.5 0.3e0.8 0.01
Type of surgery
Open 1 0.05 1 0.001
Endovascular 0.5 0.3e1.0 0.3 0.2e0.6
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cardia and impaired coronary arterial blood flow.12 This
may result in a decreased cardiac output, especially when
diastolic ventricular filling is impaired by conditions such as
hypertension and diabetes mellitus. However, most of the
pathophysiological pathways and consequences of AF are
investigated in the non-surgical population and after
cardiac surgery.6,12,13 The relationship between AF and
impaired cardiac outcome after non-cardiac surgery is less
well studied. It might be hypothesised that a sustained
state of AF after vascular surgery results in a prolonged
period of suboptimal left ventricular function and coronary
oxygen perfusion abnormalities leading to a cardiac oxygen
demand/supply mismatch, resulting in MI. Both heart
failure and MI are strong predictors of adverse post-
operative outcome.14,15 In the current study there was
a clear association between AF and myocardial ischaemia,
as shown by an increased incidence of troponin T release.
However, the relation in time could not be assessed as
troponin T release can only be assessed at intervals, hence
preventing the understanding of the exact time relation
between AF and myocardial ischaemia. Furthermore, in our
study, new-onset AF was preceded by myocardial ischaemia
in half of the cases.
The majority of studies performed to detect the impact
of AF on postoperative outcome were performed in patients
undergoing cardiothoracic surgery. In these studies, the
incidence of new-onset AF is as high as 40%.6 In the non-
cardiothoracic surgical setting, the risk for perioperative
new-onset AF is significantly lower. As reported by Chris-
tians et al., the incidence of new-onset AF in an unselected
group of 13 696 patients undergoing elective non-cardiac
surgery was as low as 0.37%.5 In specifically selected
patient populations, such as surgical ICU patients, the
incidence of new-onset AF might be as high as 9%, as
reported by Brathwaite and Weissman.4 Importantly, in this
surgical ICU study, patients with new-onset AF also had an
increased risk for mortality. Valentine et al. studied ICU
patients after open aortic surgical procedure and revealeda similar incidence of 10% new-onset AF.3 It should be
noticed that these patients were followed up with contin-
uous ECG monitoring for a mean of 6 8 days. This high
incidence of postoperative new-onset AF after aortic
surgery has recently been reconfirmed by Noorani et al.16 in
a group of 200 patients. Those with AF (10%) had an
increased risk for cardiac failure and a longer hospital stay.
In the study by Noorani et al., no relation was found
between AF and prognosis, but it was a retrospective study
with a discontinuous fashion of ECG monitoring. In the
current study, patients were followed by continuous-ECG
for 72 h and a standard ECG on days 3 and 7. This might
explain the lower incidence of new-onset AF observed in
our study. Furthermore, intermediate-risk surgical
patients, that is, endovascular aneurysm repair and
peripheral bypass surgery, were included in the current
study. This might have affected the incidence of new-onset
AF. Another possible explanation for the lower incidence of
new-onset AFmight be the use of perioperative beta-blocker
therapy in majority of the patients in the current study.
New-onset postoperative AF deserves attention, as it is
associated with poor outcome. It warrants a specific eval-
uation of the cause of AF, and a more rigorous screening for
postoperative AF should be considered. Advanced age was
a preoperative predictor of new-onset AF. As the average
age of patients scheduled for vascular surgery is increasing,
the incidence of AF after vascular surgery is likely to
increase. Therefore, development of easy-to-use moni-
toring devices, which would enable a longer continuous
monitoring period, is important.
As was found in the current study, AF after non-cardiac
surgery is often transient and causes little clinical
complaints as only three out of 15 (20%) patients required
additional medical therapy because of exacerbating heart
failure symptoms. It should be appreciated that, in the
current study, majority of the patients were on perioper-
ative beta-blocker therapy and that it was continued after
surgery intravenously or as a suppository when oral medi-
cation was not feasible. Current guidelines do not provide
688 T.A. Winkel et al.a clear strategy for asymptomatic transient AF after non-
cardiac surgery. As stated in the 2006 ACC/AHA/ESC
guidelines, administration of atrioventricular (AV)-nodal
blocking agents is recommended to achieve rate control in
patients who develop postoperative AF.12 Furthermore, it is
considered reasonable to (1) restore sinus rhythm by
pharmacological cardioversion with ibutilide or direct-
current cardioversion in patients who develop post-
operative AF as advised for non-surgical patients, (2)
administer anti-arrhythmic medications in an attempt to
maintain sinus rhythm in patients with recurrent or
refractory postoperative AF, as recommended for other
patients who develop AF and (3) administer antithrombotic
medication in patients who develop postoperative AF, as
recommended for non-surgical patients. Whether these
guidelines are also applicable to patients with transient
new-onset postoperative AF remains to be investigated.
Limitations
In the present study, continuous-ECG recordings were only
performed for 48 h after surgery. A prolonged registration
could have resulted in an increased number of patients with
AF similar to prolonged registrations at the surgical ICU
studies. In addition, analysis was done off-line, which
prevented the assessment of a potential benefit of timely
intervention.
Conclusion
New-onset AF after vascular surgery is a common, often
asymptomatic, cardiac arrhythmia and is associated with
a poor perioperative and long-term outcome.
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